2022 Epilepsy Seed-To-Sale 
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. increase in annual sales.
Cannabis Law Report
FEBRUARY 19, 2022
The AMCC anticipates that applicants may submit licenses to grow and/or manufacture medical cannabis on September 1, 2022. While cannabis legalization moves full steam ahead through much of the Northeast, the southeastern U.S. has been notably slow to uptake major reforms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
MARCH 23, 2023
The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.
CannaTech
OCTOBER 14, 2018
The bill, scheduled to take effect on January 1, 2019, allows California farmers to enter the rapidly-growing hemp industry on a wide scale, raising industrial hemp to produce hemp seed, oil, fiber, and extract for a variety of uses. These are some of the iconic images that immediately come to mind when people think of California.
Cannabis Law Report
AUGUST 12, 2021
Will Ainsworth, House Speaker Mac McCutcheon, Senate President Pro Tem Greg Reed and others appointed the 14 members, who will lead a “seed to sale” regulatory system for medical cannabis. The Alabama Medical Cannabis Commission, created by legislation that passed in May, will meet at 1 p.m. at the State House in Montgomery.
SpeedWeed
MAY 8, 2021
Some of the conditions include: cancer, terminal illness, depression, epilepsy, anxiety or panic disorder, chronic pain, spasticity, autism, Tourette syndrome and post-traumatic stress disorder. . The House is scheduled to reconvene at 8 a.m. May 6, when the bill is expected to return to the chamber’s floor. . Sponsored by Republican Sen.
SpeedWeed
MAY 6, 2021
Some of the conditions include: cancer, terminal illness, depression, epilepsy, anxiety or panic disorder, chronic pain, spasticity, autism, Tourette syndrome and post-traumatic stress disorder. . The House is scheduled to reconvene at 8 a.m. May 6, when the bill is expected to return to the chamber’s floor. . Sponsored by Republican Sen.
Expert insights. Personalized for you.
144 
Let's personalize your content